Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_assertion type Assertion NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_head.
- NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_provenance.
- NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_assertion evidence source_evidence_literature NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_provenance.
- NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_assertion SIO_000772 25339352 NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_provenance.
- NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_assertion wasDerivedFrom befree-20150227 NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_provenance.
- NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_assertion wasGeneratedBy ECO_0000203 NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_provenance.